SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Glikson M, Galun E, Oren R, Tur-Kaspa R, Shouval D. Relapsing hepatitis A: review of 14 cases and literature survey. Medicine 1992; 71:1423.MEDLINE
  • 2
    Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine 1992; 10(suppl 1:18S20S.
  • 3
    Wagstaff AJ, Plosker GL, Balfour J. Inactivated hepatitis A vaccine (HM175 Strain): a preliminary review of its immunogenicity, protective potential and tolerability in at-risk patients. Clin Immunother 1996; 6:6888.
  • 4
    Dienstag JL, Isselbacher KJ. Acute Hepatitis. In: IsselbacherKJ, BraunwaldE, WilsonJD, MartinJB, FauciAS, KasperDL, eds. Harrison's Principles of Internal Medicine. Vol 2. Ed. 13. New York: McGraw-Hill, 1994;14581477.
  • 5
    Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995; 90:201205.MEDLINE
  • 6
    Hadler SC. Global impact of hepatitis A virus infection changing patterns. In: HollingerFB, LemonSM, MargolisH, eds. Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1990;1420.
  • 7
    Yao G. Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic. In: HollingerFB, LemonSM, MargolisH, eds. Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1991;1420.
  • 8
    Fukumoto Y, Okita K, Konishi T, Takemoto T. Hepatitis A infection in chronic carriers of hepatitis B virus. In: SungJ -L, Chen D-S, eds. Viral Hepatitis and Hepatocellular Carcinoma. Amsterdam: Excerpta Medica, 1990;4348.
  • 9
    Conteas C, Kao H, Rakela J, Weliky B. Acute type A hepatitis in three patients with chronic HBV infection. Dig Dis Sci 1983; 28:684686.MEDLINE
  • 10
    Viola LA, Barrison IG, Coleman JC, Murray-Lyon IM. The clinical course of acute type A hepatitis in chronic HBsAg carriers—a report of 3 cases. Postgrad Med J 1982; 58:8081.MEDLINE
  • 11
    Zachoval R, Roggendorf M, Deinhardt F. Hepatitis A infection in chronic carriers of hepatitis B virus. Hepatology 1983; 3:528531.MEDLINE
  • 12
    Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, Suntaykorn S, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994; 271:13281334.MEDLINE
  • 13
    Riedemann S, Reinhardt G, Frösner GG, Ibarra H, Moraleda L, Hering V, Siegel F, et al. Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile. Vaccine 1992; 10(suppl 1:S152S155.MEDLINE
  • 14
    McMahon BJ, Williams J, Bulkow L, Snowball M, Wainwright R, Kennedy M, Krause D. Immunogenicity of an inactivated hepatitis A vaccine in Alaska native children and native and non-native adults. J Infect Dis 1995; 171:676679.MEDLINE
  • 15
    Príkazský V, Oleár V, Cernoch A, Safary A, André FE. Interruption of an outbreak of hepatitis A in two villages by vaccination. J Med Virol 1994; 44:457459.MEDLINE
  • 16
    Scheifele DW, Bjornson GJ. Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more. Can Med Assoc J 1993; 148:551555.
  • 17
    Anon. Public health control of hepatitis A: memorandum from a WHO meeting. Bull WHO 1995; 73:1520.
  • 18
    CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). No. RR-15 MMWR 1996; 45S:130.
  • 19
    Santagostino E, Gringeri A, Rocino A, Zanetti A, de Biasi R, Mannucci PM. Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients. Thromb Haemostasis 1994; 72:508510.
  • 20
    Hess G, Clemens R, Bienzle U, Schönfeld C, Schunck B, Bock HL. Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men. J Med Virol 1995; 46:4042.MEDLINE
  • 21
    Dentico P, Ciavarella N, Scaraggi FA, Schiavoni M, Volpe A, Fasano A, Perricci A, et al. Long-term immunogenicity and safety of an inactivated hepatitis A vaccine in haemophilic patients. Haemophilia 1996; 2:3740.
  • 22
    Horng Y-C, Chang M-H, Lee C-Y, Safary A, André FE, Chen D-S. Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers. J Gastroenterol Hepatol 1993; 8:338341.MEDLINE
  • 23
    Rothschild C, Pol S, Mattlinger B, Reijasse D, Torchet MF, Gazengel C. Vaccination against hepatitis A virus in French hemophilic children. Vox Sang 1995; 69:8081.MEDLINE
  • 24
    André FE. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. 3A Am J Med 1989; 87:14S20S.
  • 25
    André FE. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990; 8:S74S78.MEDLINE
  • 26
    Boyles S. Review of 12 million doses shows hepatitis B vaccine safe. Vaccine Wkly November 4, 1996:1315.
  • 27
    Hess G, Faatz E, Melchior W, Bayer H. Analysis of immunoassays to detect antibodies to hepatitis A virus (anti-HAV) and anti-HAV immunoglobulin M. J Virol Methods 1995; 51:221228.MEDLINE
  • 28
    Hall AJ. Hepatitis B vaccination: protection for how long and against what? BMJ 1993; 307:276277.MEDLINE
  • 29
    Van Damme P, Thoelen S, Cramm M, De Groote K, Safary A, Meheus A. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol 1994; 44:446451.MEDLINE
  • 30
    Sandman L, Davidson M, Krugman S. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals. J Inf Dis 1995; 171(suppl 1:550552.
  • 31
    Tilzey AJ, Palmer SJ, Barrow S, Perry KR, Tyrrell H, Safary A, Banatvala JE. Clinical trial with inactivated hepatitis A vaccine and recommendations for use. BMJ 1992; 304:12721276.MEDLINE
  • 32
    Goubau P, Van Gerven V, Safary A, Delem A, Knops J, D'Hondt E, André F, et al. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine. Vaccine 1992; (suppl 1):S114S118.
  • 33
    Van Damme P, Mathei C, Thoelen S, Meheus A, Safary A, André FE. Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity. J Med Virol 1994; 44:435441.MEDLINE
  • 34
    McMahon BJ, Williams J, Bulkow L, Snowball M, Wainwright R, Kennedy M, Krause D. Immunogenicity of an inactivated hepatitis A vaccine in Alaska native children and native and non-native adults. J Infect Dis 1995; 171:676679.MEDLINE
  • 35
    Briem H, Safary A. Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later. J Med Virol 1994; 44:443445.MEDLINE